Siva Sanjeeva Rao Thunuguntla

Title: Innovations of Siva Sanjeeva Rao Thunuguntla

Introduction

Siva Sanjeeva Rao Thunuguntla is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit dihydroorotate oxygenase (DHODH). With a total of 4 patents to his name, his work is paving the way for new therapeutic options in treating various diseases.

Latest Patents

One of his notable patents includes the invention of 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors. This invention provides compounds that may be therapeutically useful in treating diseases where inhibiting DHODH is advantageous. The patent also outlines methods for synthesizing these derivatives and pharmaceutical formulations that include these compounds. Another significant patent involves trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors, which are aimed at treating cancer by inhibiting tumor growth and metastasis.

Career Highlights

Siva has worked with several prominent companies in the pharmaceutical industry, including Aurigene Discovery Technologies Limited and Um Pharmauji Sdn. Bhd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Siva has collaborated with notable professionals in the field, including Subramanya Hosahalli and Satish Reddy Kunnam. These collaborations have further enhanced his research and development efforts.

Conclusion

Siva Sanjeeva Rao Thunuguntla's innovative work in the pharmaceutical sector demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of drug mechanisms and potential therapeutic applications.